USC Schaeffer Center research on “pharmacy benefit managers” has the attention of the FTC and Congress, which has called executives to testify next week.
USC study suggests Supreme Court’s abortion decision has had wider ramifications for women’s reproductive health than previously thought.
USC experts discuss how the 2022 rollback of Roe v. Wade has changed reproductive rights and access across the country, and how these critical issues might shape voter behavior and decisions in the 2024 election.
The USC Schaeffer Center study suggests that women with high-deductible health plans pay more out-of-pocket for maternity care when pregnancies span two calendar years, facing annual deductibles twice.
A recent USC study finds concerns about hospitals offering medical payment products may be overblown.
A new study by USC researchers explains why kids aren’t getting a cheap, effective treatment for diarrhea.
Elyn Saks is a renowned legal scholar and a skilled educator. She’s also a fierce advocate for mental health who evaded a dire prognosis after being diagnosed with schizophrenia at age 28.
Researchers looked at a cancer therapy drug and found biosimilars bring competition to the market, with prices declining by more than half for some versions.
Some states cap the number of ounces or grams consumers are allowed to buy — but even a little cannabis can amount to a lot of THC, said Rosalie Liccardo Pacula of the USC Price School of Public Policy.
Researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.
